Clinical Drug Experience Knowledgebase

diazoxide (hyperstat) (1 trial)

aflibercept (zaltrap) (1 trial)

allopurinol (zyloprim) (2 trials)

anakinra (kineret) (1 trial)

atorvastatin (lipitor) (1 trial)

dapagliflozin (farxiga) (2 trials)

fenofibrate (fenoglide) (1 trial)

insulin human (humulin) (10 trials)

liraglutide (victoza) (3 trials)

nicotinamide (1 trial)

otelixizumab (3 trials)

quinapril (accupril) (1 trial)

ramipril (altace) (1 trial)

sirolimus (rapamune) (3 trials)

sitagliptin (januvia) (6 trials)

sodium chloride (4 trials)

ustekinumab (stelara) (2 trials)

abatacept (orencia) (5 trials)

acetazolamide (diamox) (1 trial)

alagebrium (1 trial)

aldesleukin (proleukin) (3 trials)

alefacept (Amevive) (1 trial)

alemtuzumab (campath) (2 trials)

allogeneic pancreatic islet cells (9 trials)

alpha-1 antitrypsin (Prolastin) (2 trials)

aluminum hydroxide (Gaviscon) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (4 trials)

autologous umbilical cord blood (2 trials)

baricitinib (olumiant) (1 trial)

belatacept (nujolix) (2 trials)

bromocriptine (parlodel) (1 trial)

cyclosporine (sandimmune) (1 trial)

daclizumab (Zenapax) (1 trial)

diamyd (1 trial)

doxycycline (vibramycin) (2 trials)

efalizumab (raptiva) (4 trials)

everolimus (zortress) (1 trial)

gad-alum (2 trials)

gevokizumab (1 trial)

glucagon (4 trials)

hydroxychloroquine (plaquenil) (1 trial)

ico-007 (1 trial)

imatinib (gleevec) (1 trial)

infliximab (remicade) (1 trial)

insulin glulisine (Apidra) (1 trial)

insulin lispro (humalog) (2 trials)

lansoprazole (prevacid) (1 trial)

l. johnsonii n6.2 (2 trials)

mecamylamine (inversine) (1 trial)

methylprednisolone (medrol) (1 trial)

mycophenolate (myfortic) (1 trial)

pantoprazole (protonix) (1 trial)

prednisone (meticorten) (1 trial)

proinsulin human (1 trial)

ranibizumab (lucentis) (4 trials)

remestemcel-l (1 trial)

rituximab (rituxan) (2 trials)

sargramostim (leukine) (1 trial)

sb-509 (2 trials)

simvastatin (zocor) (1 trial)

sotagliflozin (1 trial)

teplizumab (4 trials)

ttp399 (1 trial)

ursodeoxycholyltaurine (1 trial)

verapamil (calan) (2 trials)

cepolytreg (1 trial)

ex vivo expanded human autologous polyclonal regulatory t cells (1 trial)

filgrastim (neupogen) (1 trial)

golimumab (simponi) (1 trial)

icosapent ethyl (vascepa) (2 trials)

kvd001 (1 trial)

leptin (1 trial)

maltodextrin (1 trial)

piperidic acid (1 trial)

pramlintide (symlin) (5 trials)

beta carotene (solatene) (1 trial)

fallypride (1 trial)

gamma-amino-beta-hydroxybutyric acid (1 trial)

glimepiride (amaryl) (1 trial)

insulin aspart (novolog) (3 trials)

l-cysteine (cysteine hydrochloride) (1 trial)

medium-chain fatty acids (1 trial)

medium chain triglyceride (1 trial)

methyldopa (aldomet) (1 trial)

probiotic (1 trial)

sélénium (1 trial)

vitamin c (1 trial)

vitamin d3 (1 trial)

vitamin e (1 trial)

zn2+ (1 trial)